| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.71 | 2e-09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |